The metabolic response to infection/injury has many components which may be viewed as beneficial from the perspective of the host. These include the development of specific immune responses at the site of tissue damage, limitation of the magnitude of normal tissue injury, and promotion of wound healing but also include a wide range of putatively beneficial metabolic responses such as fever, increased gluconeogenesis, host protein, and mineral redistribution, and acute phase protein synthesis. Substantial evidence has accumulated that most, and probably all of these responses, can be mimicked by the administration of a biologically derived, partially purified protein, interleukin I or LEM. Recombinant interleukin I (IL-I) and tumor necrosis factor (TNF) which are present in LEM can also produce most elements of the response, particularly when co-infused. Furthermore, highly purified soluble and particulate glucan or beta-1, 3-glucopyranose, a biological response modifier, is effective in the treatment of experimental bacterial, viral and neoplastic states and acts by a specific glucan receptor on macrophages. Malnutrition diminishes IL-1 secretion, the injury/infection response, and host resistance while nutritional repletion restores all three. However, TNF is also one of the principal mediators of the lethal effect of endotoxin. Some of the adverse effects of the injury response are mediated by prostanoid metabolism which can be favorably altered by substituting dietary omega 3 fatty acids (eicosapentaenoic and docosahexaenoic) of fish oil for omega 6 fatty acids of vegetable oils. Thus with refeeding to restore immune and metabolic responsiveness, attempts to modulate the injury response may further benefit the host. The scientific design of this proposal provides experiments to 1) document in a mammalian model the metabolic effects of individual recombinant products (IL-1 alpha, IL-6) and highly purified soluble and particulate glucans, and 2) determine the modification of the injury response induced by endotoxin and natural models of injury/infection by fish oil or fish oil structured lipid feeding.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK031933-10
Application #
3230428
Study Section
Nutrition Study Section (NTN)
Project Start
1983-04-01
Project End
1995-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
10
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02215
Qu, Z; Chow, J C; Ling, P R et al. (1997) Tissue-specific effects of chronic dietary protein restriction and gastrostomy on the insulin-like growth factor-I pathway in the liver and colon of adult rats. Metabolism 46:691-7
Ling, P R; Sierra, P; Qu, Z et al. (1997) Insulin-like growth factor-I improves glucose utilization in tumor necrosis factor-treated rats under hyperinsulinemic-euglycemic conditions. Metabolism 46:1052-8
Kwoun, M O; Ling, P R; Lydon, E et al. (1997) Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN J Parenter Enteral Nutr 21:91-5
Ling, P R; Schwartz, J H; Bistrian, B R (1997) Mechanisms of host wasting induced by administration of cytokines in rats. Am J Physiol 272:E333-9
Ling, P R; Schwartz, J H; Jeevanandam, M et al. (1996) Metabolic changes in rats during a continuous infusion of recombinant interleukin-1. Am J Physiol 270:E305-12
Chow, J C; Ling, P R; Qu, Z et al. (1996) Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Endocrinology 137:2880-6
Qu, Z; Ling, P R; Chow, J C et al. (1996) Determinants of plasma concentrations of insulin-like growth factor-I and albumin and their hepatic mRNAs: the role of dietary protein content and tumor necrosis factor in malnourished rats. Metabolism 45:1273-8
Qu, Z; Ling, P R; Tahan, S R et al. (1996) Protein and lipid refeeding changes protein metabolism and colonic but not small intestinal morphology in protein-depleted rats. J Nutr 126:906-12
Wan, J M; Istfan, N W; Ye, S L et al. (1995) Insulin-like growth factor-1 is not mitogenic for the Walker-256 carcinosarcoma. Life Sci 56:747-56
Ling, P R; Gollaher, C; Colon, E et al. (1995) IGF-I alters energy expenditure and protein metabolism during parenteral feeding in rats. Am J Clin Nutr 61:116-20

Showing the most recent 10 out of 34 publications